<analysis>
**Action 1 (Moolenaar hearing).** Anthropic will almost certainly file something, since committee requests are hard to refuse. The obstacles are elsewhere:
- Securities counsel and legal have trimmed or held outward material for four straight months.
- A signed admission that "the Missouri attack came through our advisory flaw" creates litigation exposure: a hospitalisation plus possible tort claims from the co-op's members.
- Asking for mandatory pre-deployment testing that covers open-weight release is a sweeping regulatory request that DOJ and FTC-wary counsel may soften.
- The committee is a China-hawk forum and is predisposed to the "Anthropic helps DeepSeek" frame.

The written statement will very likely go in, but with heavy trimming. Changing the story is a coin-flip at best.

**Action 2 (grid and water remediation).** This runs through channels that already cooperated in November (APPA, NRECA, WaterISAC, E-ISAC).
- **Managed mitigation on OT.** This raises liability and indemnification questions for co-ops, and uptake is slow.
- **Waivers.** Growth has run about 18–23 jurisdictions a month, so reaching 150 is unlikely.
- **vLLM.** Plausible, since the kernel work is now two months old.
- **K4 pack.** Pre-building against a preview is feasible.
- **Overall.** The action has many parts, so partial success is likely. Uptake above 45% is a stretch; about 38–40% is realistic.

**Action 3 (alignment engine).** This is internal and uses running infrastructure.
- The call-count test and timing canonicalisation are routine for the fleet.
- The pilot readout is on schedule.
- Apollo on-site or air-gapped access will not close in a month on a realistic legal timeline.
- AISI-held honeypots need AISI's cooperation, which it has offered before.
- Moderate risk.

**Action 4 (CL-5 triggers).** In December the Board stripped a defined trigger.
- One of the proposed triggers, OpenAI's claim of a full researcher, is almost certain to fire within about six weeks. That makes this in effect a spending commitment while the stock is 11% below its open.
- Reconciled fact: OpenAI publicly claimed its "automated research intern" milestone in September 2026, consistent with Altman's stated March 2028 target for a full researcher. This makes the trigger even more certain.
- The Board most likely declines. The RSP-disclosure fallback is more feasible, but counsel will review it.

**Action 5 (unilateral Release Standard).**
- Comms killed the essay twice.
- Soliciting endorsements from 212 pledge signatories, many of them employees at rival labs, looks like coordination while the DOJ review is pending.
- Publicly binding release commitments need leadership sign-off ahead of a competitive March.
- High failure risk. A pared-down version with no endorsement drive is possible.

**Action 6 (benefits).**
- The in-app launch is within Anthropic's product control, and the existing in-chat offer is the base.
- Reaching 20,000 enrolled by 31 March is a big jump from a pace of about 550–730 a month. Open enrolment could plausibly reach 8,000–15,000.
- Placements run about 7–19 a month, so 120 by March is borderline.
- The Cures Within Reach filing support is low-risk.

**Threats.**
- **Threat 1.** The joint investigation is real, and counsel is cautious. But freezing defensive packs outright is a notable step. Moderate probability.
- **Threat 2.** Public and Claude Code traffic runs through varied MCP plugins, and the classifier is new. On the other side, canonicalisation and `order_semantics` are live, and the trailing residual is 0.026 bits, well below 0.05. Plausible but less likely than the adversary claims.
- **Threat 3.** This needs the pilot to pass first, and the prior on that is modest because the character track keeps missing. Then METR, which gained access only weeks ago, must find a concentration effect within the month. A conjunction, so lower.
- **Threat 4.** It overlaps heavily with Action 4's own execution risk. The distinct part is the cascade: counsel delaying the RSP fallback and legal holding Action 5. I set it lower to avoid double-counting.
- **Threat 5.** New providers without performance data are often granted initial eligibility. But a 2.3% placement rate, no wage data and labour-aligned board members make deferral a real possibility.
</analysis>

<action_odds>
Action 1 [Moolenaar hearing testimony and model amendments]: P(failure) 55%. Reason: counsel has trimmed or held outward material four months running; a signed admission creates litigation exposure over the hospitalisation; the forum is hostile and primed for the China frame; a statement will be filed, but shifting the story is unlikely.

Action 2 [Grid and water remediation via NRECA/APPA/ISACs, packs, waivers]: P(failure) 40%. Reason: the channels are proven and vLLM and K4 packs are feasible; but managed OT mitigation raises liability issues, 150 waivers is about 5× the recent pace, and 45% uptake is a stretch; many sub-parts.

Action 3 [Residual test, timing canon, pilot readout, go/no-go, Apollo, CL-5 runs]: P(failure) 30%. Reason: internal work on running infrastructure; Apollo access and AISI honeypots depend on outside timelines; the pilot readout itself may be negative, but reporting it counts as execution.

Action 4 [Board pre-commits objective CL-5 triggers]: P(failure) 60%. Reason: the Board stripped a defined trigger two months ago; this trigger fires almost certainly within weeks (OpenAI's September 2026 intern claim and March target), making it a de facto compute spend while the stock is down; the RSP-disclosure fallback is only partially plausible.

Action 5 [Unilateral Automated Research Release Standard]: P(failure) 60%. Reason: the rival-commentary rule, the DOJ/FTC caution, and an endorsement drive among rival-lab signatories that looks like coordination; binding release commitments ahead of March need leadership sign-off.

Action 6 [In-app Claude Works, WA ETPL, apprenticeships, Cures Within Reach]: P(failure) 35%. Reason: the product launch is within Anthropic's control and the filing support is low-risk; the 20k enrolment and 120-placement targets far exceed trend, so even success will be partial; the WA outcome is handled by Threat 5.
</action_odds>

<threat_odds>
Threat 1 [Hearing becomes PRC-support probe, packs frozen]: P(materialises) 35%. Adversary suggested 40%. The joint investigation and counsel's pattern are real, but a full freeze of defensive tooling, including the K4 pack, is a bigger step than trimming testimony, so slightly lower.

Threat 2 [Public 5.3 traffic trips rollback threshold]: P(materialises) 22%. Adversary suggested 30%. Consumer and Claude Code plugin diversity and an uncalibrated classifier are real risks, but `order_semantics`, canonicalisation and a 0.026-bit trailing residual (half the threshold) mean a 72-hour average above 0.05 bits needs a sizeable new source.

Threat 3 [Pilot passes via evaluation awareness, sign-off withheld]: P(materialises) 18%. Adversary suggested 35%. This is a conjunction: the pilot must first pass (low prior given repeated character misses), then METR, with only weeks of ledger access, must localise the effect within the month.

Threat 4 [Board declines triggers; counsel delays fallback and holds the Standard]: P(materialises) 30%. Adversary suggested 50%. The Board's refusal is already priced into Action 4's P(failure); this covers only the added cascade of counsel delaying the RSP fallback and legal holding the Standard, which Action 5's odds partly cover too. I accept the adversary's reconciled fact about OpenAI's September 2026 intern milestone.

Threat 5 [WA ETPL defers or denies on outcome data]: P(materialises) 40%. Adversary suggested 45%. New providers often receive initial eligibility without full performance data, but a 2.3% placement rate, no wage or retention data and labour pressure on the board make deferral a near coin-flip.
</threat_odds>
